Real World Evidence of Efficacy of CPX-351 in Secondary Acute Myeloid Leukemia Defined According to Who 2022 Classification

被引：0
|
作者：
Riva, Carola [1 ]
Minetto, Paola [2 ]
Chies, Maria [1 ]
Uernarecci, Chiara [1 ]
Zecchetti, Giada [1 ]
Maio, Elena [1 ]
Azzanelli, Ylenia [1 ]
Colombo, Nicoletta [2 ,3 ]
Rosellini, Sara [3 ]
Parodi, Alessia [3 ]
Tedone, Elisabetta [2 ,3 ]
Carminati, Enrico [2 ]
Puglisi, Francesco [1 ]
Nurra, Clara [1 ]
Fugazza, Giuseppina [1 ]
Nozza, Paolo [2 ]
Cea, Michele [1 ,2 ]
Lemoli, Roberto Massimo [1 ,4 ]
Guolo, Fabio [2 ,5 ]
机构：
[1] Univ Genoa, Dept Internal Med DiMI, Clin Hematol, Genoa, Italy
[2] IRCCS Osped Policlin San Martino, Genoa, Italy
[3] IRCCS Osped Policlin San Martino, Dipartimento Anat Patol, Serv Citofluorimetria, Genoa, Italy
[4] IRCCS Osped Policlin San Martino, Dipartimento Oncol & Ematol, Clin Ematol, Genoa, Italy
[5] Univ Genoa, Dept Internal Med DiMI, Clin Hematol, Hematol Unit, Genoa, Italy
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-197943
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1471 / 1472
页数：2
相关论文
共 50 条
  • [1] Efficacy and Safety Profile of CPX-351 in Secondary Acute Myeloid Leukemia (sAML): A Systematic Review
    Ibrahim, Ahmed
    Yousaf, Muhammad Abdullah
    Ikram, Mariam
    Khalid, Huma
    Anum
    Safdar, Omar A.
    Anwer, Zain
    Faraz, Fatima
    Rehman, Mohammad
    Saad, Muhammad
    BLOOD, 2023, 142
  • [2] Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia
    Matthews, Andrew H.
    Perl, Alexander E.
    Luger, Selina M.
    Loren, Alison W.
    Gill, Saar I.
    Porter, David L.
    Babushok, Daria V.
    Maillard, Ivan P.
    Carroll, Martin P.
    Frey, Noelle V.
    Hexner, Elizabeth O.
    Martin, Mary Ellen
    McCurdy, Shannon R.
    Stadtmauer, Edward A.
    Paralkar, Vikram R.
    Bruno, Ximena Jordan
    Hwang, Wei -Ting
    Margolis, David
    Pratz, Keith W.
    BLOOD ADVANCES, 2022, 6 (13) : 3997 - 4005
  • [3] Real World Outcomes of CPX-351 Compared to Traditional Chemotherapy with Cytarabine Consolidation for Treatment of Secondary Acute Myeloid Leukemia
    Granger, Katelynn
    Gaffney, Kelly J.
    Smith, Deidra
    Weeda, Erin
    Baratam, Praneeth
    Green, Kimberly Michelle
    Coltoff, Alexander
    Davis, James A.
    BLOOD, 2023, 142
  • [4] Real-world experience with CPX-351 in high-risk acute myeloid leukemia
    Lemoli, Roberto M.
    Montesinos, Pau
    Jain, Akriti
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 185
  • [5] CPX-351: changing the landscape of treatment for patients with secondary acute myeloid leukemia
    Talati, Chetasi
    Lancet, Jeffrey E.
    FUTURE ONCOLOGY, 2018, 14 (12) : 1147 - 1154
  • [6] Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia
    Przespolewski, Amanda
    Goldberg, Aaron D.
    Talati, Chetasi
    Fazal, Salman
    Vachhani, Pankit
    Sanikommu, Srinivasa R.
    Thota, Swapna
    Waksal, Julian
    Ball, Brian
    Famulare, Christopher
    Stahl, Maximilian
    Baron, Jeffrey
    Griffiths, Elizabeth A.
    Thompson, James E.
    Sweet, Kendra
    Wang, Eunice S.
    BLOOD, 2023, 141 (12) : 1489 - 1493
  • [7] Real-World Outcomes with CPX-351 Induction in Adults with Newly Diagnosed Acute Myeloid Leukemia
    Bennett, Joseph G.
    Gilmore, Drake
    Male, Heather J.
    Byrd, Kenneth P.
    Lin, Tara L.
    Gonzalez-Lugo, Jesus D.
    BLOOD, 2023, 142
  • [8] Real-World Study of CPX-351 Treatment Outcomes for Acute Myeloid Leukemia (AML) in England
    Legg, Alex
    Doubleday, Pesheya
    Reich, Adam
    Lambova, Alexandrina
    Medalla, Greg
    BLOOD, 2021, 138
  • [9] Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia
    Christina Rautenberg
    Friedrich Stölzel
    Christoph Röllig
    Matthias Stelljes
    Verena Gaidzik
    Michael Lauseker
    Oliver Kriege
    Mareike Verbeek
    Julia Marie Unglaub
    Felicitas Thol
    Stefan W. Krause
    Mathias Hänel
    Charlotte Neuerburg
    Vladan Vucinic
    Christian-Friedrich Jehn
    Julia Severmann
    Maxi Wass
    Lars Fransecky
    Jens Chemnitz
    Udo Holtick
    Kerstin Schäfer-Eckart
    Josephine Schröder
    Sabrina Kraus
    William Krüger
    Ulrich Kaiser
    Sebastian Scholl
    Kathrin Koch
    Lea Henning
    Guido Kobbe
    Rainer Haas
    Nael Alakel
    Maximilian-Alexander Röhnert
    Katja Sockel
    Maher Hanoun
    Uwe Platzbecker
    Tobias A. W. Holderried
    Anke Morgner
    Michael Heuser
    Tim Sauer
    Katharina S. Götze
    Eva Wagner-Drouet
    Konstanze Döhner
    Hartmut Döhner
    Christoph Schliemann
    Johannes Schetelig
    Martin Bornhäuser
    Ulrich Germing
    Thomas Schroeder
    Jan Moritz Middeke
    Blood Cancer Journal, 11
  • [10] Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia
    Rautenberg, Christina
    Stoelzel, Friedrich
    Roellig, Christoph
    Stelljes, Matthias
    Gaidzik, Verena
    Lauseker, Michael
    Kriege, Oliver
    Verbeek, Mareike
    Unglaub, Julia Marie
    Thol, Felicitas
    Krause, Stefan W.
    Haenel, Mathias
    Neuerburg, Charlotte
    Vucinic, Vladan
    Jehn, Christian-Friedrich
    Severmann, Julia
    Wass, Maxi
    Fransecky, Lars
    Chemnitz, Jens
    Holtick, Udo
    Schaefer-Eckart, Kerstin
    Schroeder, Josephine
    Kraus, Sabrina
    Krueger, William
    Kaiser, Ulrich
    Scholl, Sebastian
    Koch, Kathrin
    Henning, Lea
    Kobbe, Guido
    Haas, Rainer
    Alakel, Nael
    Roehnert, Maximilian-Alexander
    Sockel, Katja
    Hanoun, Maher
    Platzbecker, Uwe
    Holderried, Tobias A. W.
    Morgner, Anke
    Heuser, Michael
    Sauer, Tim
    Goetze, Katharina S.
    Wagner-Drouet, Eva
    Doehner, Konstanze
    Doehner, Hartmut
    Schliemann, Christoph
    Schetelig, Johannes
    Bornhaeuser, Martin
    Germing, Ulrich
    Schroeder, Thomas
    Middeke, Jan Moritz
    BLOOD CANCER JOURNAL, 2021, 11 (10)
12345